Contact PI/Project LeaderGRINSTAFF, MARK W. Other PIs
Awardee OrganizationBOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
Description
Abstract Text
ABSTRACT
This application proposes the third renewal of Boston University's NIH training program, Translational Re-
search in Biomaterials (TRB). The TRB mission is to train PhD students as interdisciplinary and transla-
tional research scientists and engineers. The TRB trainees acquire a fundamental and quantitative under-
standing of materials, biomaterial-tissue responses, and molecular and cell biology, as well as interdiscipli-
nary training experiences and education that promote discussion and scientific inquiry in areas outside stu-
dents’ “comfort zones,” such as in business and clinical trials. New for this renewal are the following: a jun-
ior faculty mentoring plan, integrated student governance, better data collection, new courses, professional
development workshops, student founded and led translational MInT program, Fireside chats with key opin-
ion-leaders, peer mentoring program pairing first year trainees with senior trainees, and more targeted ef-
forts for underrepresented minority recruitment.
The cornerstones of the TRB program are the curriculum and the program elements that combine interdis-
ciplinary research, quantitative science, engineering, and translational-based courses in clinical trials and
business, with student-organized seminar club, dinners with clinicians, training in professional ethics, indi-
vidual development plans, and professional workshops/ career panels. Our aim is to teach the unique skills
and competencies that are essential to thrive in a multidisciplinary collaborative team striving to meet com-
mon goals in research, development, translation, and, ultimately, commercialization. Since our initial funding
in 2009, 44 students have participated in the TRB training program: 33 were supported with NIH funds and
11 were co-funded by the BU Departments of Biomedical Engineering and Chemistry. We have accom-
plished our demographic and training mission: 21 women (47%), 23 men (53%), 36% minority, 91% reten-
tion; 100% employment; 22 current students. The TRB trainees have excelled on multiple fronts, including
publications (112 published papers with 57 first-authored; five in review; five in preparation), patent applica-
tions (14), oral (56) and poster (177) conference presentations, competitive individual fellowships (19), and
other awards (27). TRB alumni hold positions ranging from Assistant Professor at Rice University, to a
postdoctoral fellowship at Harvard, to co-founding biomedical start-ups (e.g., Pharmachk). In this renewal,
the continuation of the TRB, with six trainee stipends per year funded via NIH (trainees are supported for
two years) is aligned with the expertise of participating faculty, the availability of a large and strong applicant
pool eligible for and interested in the TRB program (200+ training grant eligible applicants), and an extramu-
ral funding base to provide the appropriate research environment and continued support for NIH trainees
beyond their first two years.
Public Health Relevance Statement
NARRATIVE
Training young scientists and engineers in translational research in biomaterials facilitates the translation of
biomaterials-based technologies to the clinic. Specifically, the Translational Research in Biomaterials
(TRB) curriculum enables students to develop the creative, analytical, quantitative, and professional skills
they need to make new discoveries that will revolutionize fields ranging from diagnostics and drug delivery
to tissue engineering. These advances will improve patient care in multiple areas of medicine and ensure an
academic and industrial workforce to meet the challenges of the 21st century.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
049435266
UEI
THL6A6JLE1S7
Project Start Date
01-September-2009
Project End Date
31-August-2027
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$305,480
Direct Costs
$319,344
Indirect Costs
$16,428
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$305,480
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5T32EB006359-15
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32EB006359-15
Patents
No Patents information available for 5T32EB006359-15
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32EB006359-15
Clinical Studies
No Clinical Studies information available for 5T32EB006359-15
News and More
Related News Releases
No news release information available for 5T32EB006359-15
History
No Historical information available for 5T32EB006359-15
Similar Projects
No Similar Projects information available for 5T32EB006359-15